FDA Webview cited a recent firm Non-binding Guidance podcast in an article about the U.S. Food and Drug Administration’s final guidance on clinical decision support (CDS) software.
The final guidance represents a substantial change in FDA’s approach to CDS software regulation from the agency’s 2019 draft guidance and may prompt many software developers to reassess their CDS products in light of the new guidance. The article features a quote from life sciences regulatory & compliance partner and chair Greg Levine.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.